Citigroup’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$718K Sell
982,467
-39,414
-4% -$28.8K ﹤0.01% 2705
2025
Q1
$825K Buy
1,021,881
+541,280
+113% +$437K ﹤0.01% 2664
2024
Q4
$663K Sell
480,601
-38,202
-7% -$52.7K ﹤0.01% 2843
2024
Q3
$540K Buy
518,803
+54,348
+12% +$56.5K ﹤0.01% 2945
2024
Q2
$804K Sell
464,455
-52,261
-10% -$90.4K ﹤0.01% 2394
2024
Q1
$1.23M Buy
516,716
+142,909
+38% +$342K ﹤0.01% 2210
2023
Q4
$1.24M Sell
373,807
-423,490
-53% -$1.41M ﹤0.01% 1992
2023
Q3
$2.98M Buy
797,297
+289,194
+57% +$1.08M ﹤0.01% 1269
2023
Q2
$2.17M Sell
508,103
-361,210
-42% -$1.54M ﹤0.01% 1635
2023
Q1
$5.95M Buy
869,313
+102,229
+13% +$699K ﹤0.01% 1039
2022
Q4
$6.08M Sell
767,084
-70,631
-8% -$559K ﹤0.01% 989
2022
Q3
$8.05M Buy
837,715
+68,015
+9% +$654K 0.01% 882
2022
Q2
$5.57M Buy
769,700
+84,908
+12% +$615K ﹤0.01% 1075
2022
Q1
$8.84M Sell
684,792
-109,604
-14% -$1.41M 0.01% 955
2021
Q4
$12.7M Buy
794,396
+151,196
+24% +$2.41M 0.01% 838
2021
Q3
$10.3M Sell
643,200
-211,109
-25% -$3.39M 0.01% 976
2021
Q2
$11.8M Buy
854,309
+71,811
+9% +$993K 0.01% 965
2021
Q1
$11.4M Buy
782,498
+222,573
+40% +$3.25M 0.01% 957
2020
Q4
$9.73M Buy
559,925
+32,630
+6% +$567K 0.01% 976
2020
Q3
$9.67M Buy
527,295
+49,901
+10% +$915K 0.01% 863
2020
Q2
$8.53M Buy
477,394
+401,905
+532% +$7.18M 0.01% 848
2020
Q1
$1.22M Buy
75,489
+32,190
+74% +$522K ﹤0.01% 1666
2019
Q4
$780K Sell
43,299
-44,229
-51% -$797K ﹤0.01% 2362
2019
Q3
$1.77M Buy
87,528
+771
+0.9% +$15.6K ﹤0.01% 1707
2019
Q2
$1.92M Sell
86,757
-8,803
-9% -$195K ﹤0.01% 1661
2019
Q1
$1.3M Sell
95,560
-25,136
-21% -$343K ﹤0.01% 1783
2018
Q4
$1.09M Buy
120,696
+74,804
+163% +$677K ﹤0.01% 1946
2018
Q3
$757K Sell
45,892
-121,733
-73% -$2.01M ﹤0.01% 2203
2018
Q2
$2.35M Buy
167,625
+34,091
+26% +$477K ﹤0.01% 1404
2018
Q1
$1.48M Buy
133,534
+95,203
+248% +$1.05M ﹤0.01% 1600
2017
Q4
$337K Buy
38,331
+9,260
+32% +$81.4K ﹤0.01% 2638
2017
Q3
$387K Buy
29,071
+6,204
+27% +$82.6K ﹤0.01% 2573
2017
Q2
$328K Buy
22,867
+22,856
+207,782% +$328K ﹤0.01% 2661
2017
Q1
$0 Sell
11
-57,457
-100% ﹤0.01% 4801
2016
Q4
$1.62M Buy
57,468
+34,971
+155% +$985K ﹤0.01% 2015
2016
Q3
$603K Buy
22,497
+5,064
+29% +$136K ﹤0.01% 2307
2016
Q2
$294K Buy
17,433
+351
+2% +$5.92K ﹤0.01% 2582
2016
Q1
$363K Buy
17,082
+11,273
+194% +$240K ﹤0.01% 2978
2015
Q4
$134K Buy
5,809
+5,801
+72,513% +$134K ﹤0.01% 3351
2015
Q3
$0 Sell
8
-351
-98% ﹤0.01% 5243
2015
Q2
$11K Sell
359
-18,507
-98% -$567K ﹤0.01% 4537
2015
Q1
$577K Buy
18,866
+17,500
+1,281% +$535K ﹤0.01% 2166
2014
Q4
$22K Buy
+1,366
New +$22K ﹤0.01% 4544